Business · 1 sources covering this

Wockhardt targets 50% of revenue from novel drugs within five years

Wockhardt expects novel drugs to contribute over half its revenue within five years as it expands a differentiated antibiotic portfolio built through decades of R&D

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Wockhardt targets 50% of revenue from novel drugs within five years
Wockhardt expects novel drugs to contribute over half its revenue within five years as it expands a differentiated antibiotic portfolio built through decades of R&D
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/5d2bc0b4b79f8d7f39925f170ab2fa17a65e3116"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Wockhardt targets 50% of revenue from novel drugs within five years"></iframe>

Wockhardt targets 50% of revenue from novel drugs within five years

How 1 sources are covering this

Wockhardt targets 50% of revenue from novel drugs within five years

More from Business

In IT dept vs Reliance Foundation, a win for Ambanis

CD rates may fall up to 100 bps

Airtel to continue postpaid plan despite backlash

Japanese co eyes $150m stake in Continuum Green

Reader

Trust & legal

Across the network